Trade Summary

2 days ago, Scholl Hendrik Peter, serving as Chief Medical Officer at BELITE BIO, INC (BLTE), sold 10,000 shares at $140.57 per share, for a total transaction value of $1,405,729.41. Following this transaction, Scholl Hendrik Peter now holds 25,000 shares of BLTE.

This sale represents a 28.57% decrease in Scholl Hendrik Peter's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 6:03 AM ET, 1 day after the trade was made.